Anzeige
Mehr »
Login
Freitag, 15.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Investment in die Zukunft: Absoluter Geheimtipp - diese Aktie beschleunigt deine Renditechancen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QCUH | ISIN: SE0014855029 | Ticker-Symbol: 8IM1
Tradegate
13.11.24
16:08 Uhr
3,335 Euro
-0,075
-2,20 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
IMPLANTICA AG SDR Chart 1 Jahr
5-Tage-Chart
IMPLANTICA AG SDR 5-Tage-Chart
RealtimeGeldBriefZeit
3,6803,75514.11.

Aktuelle News zur IMPLANTICA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoImplantica submits FDA PMA application Clinical Module 2 for RefluxStop for U.S. market approval145VADUZ, Liechtenstein, Nov. 14, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device...
► Artikel lesen
08.11.Implantica presents the third quarter 2024 on November 15 at 15:00 CEST190VADUZ, Liechtenstein, Nov. 8, 2024 /PRNewswire/ -- Implantica AG (publ) invites investors to a presentation of the third quarter 2024 at 15:00 CET on November 15. The interim report for the...
► Artikel lesen
10.10.Implantica announces highly successful 2024 American Foregut Society meeting where RefluxStop received remarkable pre-launch market feedback326VADUZ, Liechtenstein, Oct. 10, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, is pleased to report an impressive...
► Artikel lesen
10.10.Implantica announces highly successful 2024 American Foregut Society meeting where RefluxStop® received remarkable pre-launch market feedback4
01.10.Implantica welcomes 23 top anti-reflux surgeons from 17 leading centers in the first User meeting in Spain, 1.5 years post country launch266VADUZ, Liechtenstein, Oct. 1, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, announces that the first Spanish...
► Artikel lesen
25.09.Implantica shares a landmark review article on standard of care Nissen Fundoplication anti-reflux surgery - in light of the recently announced excellent RefluxStop 5-year results322VADUZ, Liechtenstein, Sept. 25, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device...
► Artikel lesen
IMPLANTICA Aktie jetzt für 0€ handeln
25.09.Implantica announces finalization of remarkable 5-year pivotal CE mark study results and gears up for the Module 2 submission of PMA application to FDA for RefluxStop261VADUZ, Liechtenstein, Sept. 25, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device...
► Artikel lesen
19.09.Implantica conducts first national RefluxStop User meeting with 21 participating surgeons, 1.5 years after launch in Italy346VADUZ, Liechtenstein, Sept. 19, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, had the pleasure to host a...
► Artikel lesen
18.09.Implantica announces excellent data from an independent study of 158 RefluxStop patients from two centers in Germany - presented at the AUGIS meeting in UK365VADUZ, Liechtenstein, Sept. 18, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, reports that the study "Pooled...
► Artikel lesen
11.09.Implantica mourns the death of board member Prof. Dr. Klaus Neftel8
21.08.Implantica publishes Interim Report January - June 2024 (Q2)561VADUZ, Liechtenstein, Aug. 21, 2024 /PRNewswire/ -- RefluxStop is on a wave of success - carried by a multitude of published studies with excellent outcomes from leading European Reflux-centers Significant...
► Artikel lesen
20.08.Implantica announces RefluxStop pivotal 4-year study results published in the prestigious journal Surgical Endoscopy403VADUZ, Liechtenstein, Aug. 20, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, announces excellent long-term...
► Artikel lesen
15.08.Implantica announces another landmark real-world RefluxStop study demonstrating excellent outcomes published in a prestigious top-tier journal303VADUZ, Liechtenstein, Aug. 15, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, announces another key milestone...
► Artikel lesen
14.08.Implantica presents the second quarter 2024 on August 21 at 15:00 CEST275VADUZ, Liechtenstein, Aug. 14, 2024 /PRNewswire/ -- Implantica AG (publ) invites investors to a presentation of the second quarter 2024 at 15:00 CEST on August 21. The interim report for...
► Artikel lesen
30.07.Implantica announces excellent RefluxStop investigator initiated study results published in Scientific Reports, a Nature journal318VADUZ, Liechtenstein, July 30, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, announces the independent study...
► Artikel lesen
25.07.Implantica announces continuing progress in modular PMA application to FDA for RefluxStop396VADUZ, Liechtenstein, July 25, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device RefluxStop...
► Artikel lesen
18.07.Implantica launches RefluxStop advanced education program in Spain305VADUZ, Liechtenstein, July 18, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, brings together top anti-reflux...
► Artikel lesen
11.07.Implantica announces new health-economics data publication showing RefluxStop's superior cost-effectiveness for the Swiss healthcare system517VADUZ, Liechtenstein, July 11, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, reports the study, "Analysis...
► Artikel lesen
19.06.Implantica announces further expansion of RefluxStop access in the UK NHS public Hospital Network710VADUZ, Liechtenstein, June 19, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, announces that another NHS...
► Artikel lesen
23.05.Bulletin from the Annual General Meeting of Implantica AG611Today, May 22, 2024, the annual general meeting (the "AGM") of Implantica AG (publ) was held in Ruggel, Liechtenstein. The general meeting resolved to adopt all of the board of directors'...
► Artikel lesen
Seite:  Weiter >>
44 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1